Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)

NCT04968106 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Resectable Sarcoma

Interventions

DRUG: Doxorubicin
DRUG: Ifosfamide
DRUG: INCMGA00012

Sponsor

Institut Bergonié

Collaborators

[object Object]